All News KPC Pharmaceuticals,Inc.

Equities

600422

CNE0000015P8

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 14/07/2024 BST			5-day change	1st Jan Change
16.99 ^CNY	-0.18%		-1.96%	-18.55%

06-08	KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion.	CI
04-19	KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion.	06-07	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
Kunyao Group Receives Clinical Trial Approval for FMF Drug	04-17	MT
KPC Pharmaceuticals,Inc Proposes Cash Dividend	03-21	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023	03-21	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
KPC Pharmaceuticals’ Antimalarial Drug Passes WHO Prequalification	13/10/23	MT
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	30/08/23	MT
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%	28/04/23	MT
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
KPC Pharma’s Shingles Drug Added to China’s Medical Insurance Catalog	20/01/23	MT
KPC Pharma to Hold Phase II Clinical Trial of Stroke Drug	20/01/23	MT
China Resources Pharmaceutical Completes Transfer of KPC Pharmaceutical Shares to Unit	03/01/23	MT
KPC Pharmaceuticals CFO Steps Down	02/01/23	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.	29/12/22	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22	CI
KPC Pharmaceuticals Unit Receives Marketing Authorization of Angong Niuhuang Pills; Shares Jump 7%	21/10/22	MT
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	15/08/22	CI
Chinese Shares Rebound; KPC Pharma Rallies 10% on CR Sanjiu’s $431 Million Stake Purchase	10/05/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News KPC Pharmaceuticals,Inc.

Equities

600422

CNE0000015P8

All News

Filters